Best Dme Podcasts (2026)

1
2026 DME Final Rule Explained 26:54

Play Pause

16d ago26:54

26:54

We unpack the 2026 CMS DME final rule with an eye on what changes first, what it costs, and how suppliers can adapt without disrupting patient care. Annual surveys, stricter accreditation oversight, and targeted incentives reshape strategy, budgets, and daily operations. • Annual surveys begin at next initial or reaccreditation after 1 January 2026…

1
DME, DR, and Next-Generation Therapies 17:19

19d ago17:19

17:19

How should retina specialists integrate next-generation anti-VEGF agents into real-world DME care? In this episode of “Anti-VEGFs: The Next Generation,” David Miller, MD, speaks with Esther Kim, MD, and Ehsan Rahimy, MD, about first-line agent selection, when to transition to newer options, how to incorporate steroids thoughtfully, and crafting dos…

1
New Retina Radio Journal Club w/ VBS: Assessing Surgical Competency Among Retina Fellows: Perspectives from Directors and Graduates 21:18

17d ago21:18

21:18

How do we know when a retina fellow is truly ready for independent surgery? Nikisha Kothari, MD, moderates a discussion with Jesse Sengillo, MD, and Nicholas Farber, MD, about a new survey study comparing perspectives from fellowship program directors and recent graduates on surgical volumes, teaching tools, autonomy, and competency benchmarks. The…

1
Improving Tactical Performance with Science 1:54:23

8d ago1:54:23

1:54:23

Guest: Dr. Nathalie Pattyn In this episode, Jon sits down with Dr. Nathalie Pattyn, whose unique background spans medicine, psychology, research, and military operations. Dr. Pattyn discusses her unconventional career path from aspiring astronaut to emergency physician to tactical performance researcher, including her work in extreme environments l…

1
2026 Home Health Final Rule Explained 25:27

9d ago25:27

25:27

We break down the 2026 home health final rule, from the 1.3 percent cut and sequestration impact to face-to-face, OASIS, HHCAHPS, and value-based purchasing changes. We share concrete steps to shore up documentation, data, and budgets before January 1, 2026. • Why the final rule timing compresses preparation • Payment impact of the 1.3 percent cut …

1
The Whistleblower Update 30:37

10d ago30:37

30:37

Whistleblower attorney Max Volman will return to the next Monitor Monday broadcast to report the latest news about whistleblowers. As we have learned, often “whistleblowers” are not insiders reporting wrongdoing; they tend to be outside the offending organization. Register now to listen to Max Voldman’s exclusive report. Broadcast segments will als…

1
Navigating the Evolving Payer Landscape: Key Insights for DMEs 12:04

15d ago12:04

12:04

In this episode of the Industry Matters podcast, hosts Tyler Coulander and Alan Morris explore the rapidly changing payer landscape and its impact on the Durable Medical Equipment (DME) industry. Get the latest insights on Medicare Advantage, private insurance, and Medicaid, and learn how these shifts could affect your business strategy. What you’l…

1
Wet AMD and Next-Generation Therapies 17:51

16d ago17:51

17:51

How should retina specialists integrate next-generation anti-VEGFs into everyday wet AMD care? In this episode of “Anti-VEGFs: The Next Generation,” David Miller, MD, speaks with Esther Kim, MD, and Ehsan Rahimy, MD, about real-world issues facing wet AMD care, such as navigating crowded drug fridges, attempting interval extensions, and switching f…

1
The Fatal Blow: “Statistically Valid Extrapolation” 29:25

25d ago29:25

29:25

For years, federal audit contractors have treated statistical extrapolation as the unassailable engine driving massive overpayment demands. The premise sounds reasonable enough: review a small sample of claims, calculate an error rate, and multiply across the entire population to produce a "statistically valid" overpayment figure. In a perfect worl…

1
Retinal Fluid Fluctuation’s Impact on Long-Term Visual Acuity (Ep. 3 of 3) 28:51

21d ago28:51

28:51

Can smarter strategies to tame retinal fluid fluctuations actually improve long-term vision? In episode 3 of this miniseries, host Jay Sridhar, MD, and panelists Durga Borkar, MD, MMCi, and Christina Weng, MD, MBA, examine the data linking sustained delivery of therapy, reductions in retinal thickness changes, and positive long-term vision outcomes…

1
Retinal Fluid Fluctuation’s Impact on Long-Term Visual Acuity (Ep. 2 of 3) 27:04

21d ago27:04

27:04

Do retinal fluid fluctuations quietly erode long-term vision? In episode 2 of a 3-part roundtable series, moderator Jay Sridhar, MD joins guests Maggie Runner, MD, and Veeral Sheth, MD, MBA, to translate key data into clinic-ready tactics. They unpack how volatility—not just volume—of fluid correlates with outcomes, which fluid compartments matter …

1
Retinal Fluid Fluctuation’s Impact on Long-Term Visual Acuity (Ep. 1 of 3) 29:02

21d ago29:02

29:02

In this first episode of a 3-part roundtable series, moderator Jay Sridhar, MD, speaks with David Sarraf, MD, and Danny Mammo, MD, about retinal fluid fluctuation as a modifiable driver of outcomes in neovascular AMD and DME. The panel defines fluctuation across compartments, examines practical barriers to longitudinal OCT tracking, and assesses th…

1
Beyond the Loop: Why Everything You Know About OODA May Be Wrong 1:40:45

22d ago1:40:45

1:40:45

John Boyd's OODA loop is widely referenced but fundamentally misunderstood. Mark McGrath reveals how the common circular diagram represents less than one percent of Boyd's work. The real framework centers on orientation—constantly updating mental models through destruction and creation. This conversation explores entropy, uncertainty, and incomplet…

1
The Feds Blow the Whistle: A $45 Million Wound Care Settlement 31:50

24d ago31:50

31:50

The False Claims Act (FCA) suit was initiated by the U.S. government, not a traditional whistleblower. Nonetheless, the recent $45 million settlement with a Florida physician and his wound care group – Vohra Wound Physicians Management LLC – resolved allegations that group knowingly submitted claims to Medicare for medically unnecessary yet lucrati…

1
Global Discussions in GA: Educating Patients and Encouraging Follow-Up 22:49

1M ago22:49

22:49

How are the world's leading mind on GA management educating patients about GA so they follow-up with their providers? Host Anat Loewenstein, MD, convenes a roundtable with Jordi Monés, MD, PhD; Sobha Sivaprasad, MD; and Giovanni Staurenghi, MD, to review their specific approaches to GA management, patient conversations, and education for patients a…

1
Global Discussions in GA: Referral Patterns and Fellow-Eye Monitoring 13:00

1M ago13:00

13:00

At what point in their disease do world-renowned retina specialists want to see patients with GA? Host Anat Loewenstein, MD, leads a candid roundtable with Jordi Monés, MD, PhD; Sobha Sivaprasad, MD; and Giovanni Staurenghi, MD, on modern referral patterns, monitoring intervals, and fellow-eye surveillance. The panel explores the utility of OCT and…

1
Providers Appear More Aggressive in Defending Revenue 27:44

1M ago27:44

27:44

It’s raining RACs. And many other third party auditors. It seems like every submission of medical records is being scrutinized for omission and commission. Then enter artificial intelligence (AI). The use of AI in auditing, although relatively new, is here to stay. How is your facility faring compared to your peers? More audits? Less auditing? More…

1
Endophthalmitis Rates With and Without Antibiotic Prophylaxis 15:36

1M ago15:36

15:36

Does antibiotic prophylaxis prior to intravitreal injection affect the risk of endophthalmitis? Join New Retina Radio Journal Club with VBS moderator Alexis Warren, MD, as she and panelists Sruthi Arepalli, MD, and Jesse Sengillo, MD, sort out the details of a recent paper and discuss whether these findings alter clinical practice.…

1
John B. Buse, MD, PhD / Pam R. Taub, MD, FACC, FASPC - To Glycemia and Beyond: Managing Cardiovascular Risk in People With Type 2 Diabetes Using Incretin-Based Therapies 1:03:31

2M ago1:03:31

1:03:31

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups. For the full presentation, downloadable Practice Aids, slides, and complete CME/AAPA information, and to apply for credit, please visit us at PeerView.com/ZSR865. CME/AAPA c…

1
Resupply Revolution: Automation, Strategy & Success in HME 21:30

2M ago21:30

21:30

In this episode, we dive deep into the evolving world of HME resupply with Kevin Myers, Account Manager at Brightree, and Boone Lockard, VP of Clinical Services at VGM & Associates. From the traditional resupply methods to advanced automation, our guests unpack the operational impact of modernizing resupply programs. Learn how to optimize your busi…

1
Barricade Erupts into Urgent HRT When Freed Victim Returns to Hostage Taker 1:27:04

1M ago1:27:04

1:27:04

A three-month homicide investigation in Washington State led to a suspect barricaded in a vehicle inside a garage. What began as a routine containment evolved into a seven-hour standoff, which suddenly escalated when the freed domestic violence victim returned to the residence and was taken hostage. Joel Anderson and Bob Shaw detail the tactical ch…

1
DME 09 - Barricade Erupts into Urgent HRT 13:20

1M ago13:20

13:20

DME 09 - Barricade Erupts into Urgent HRTBy Jon Becker

1
IM: Unfiltered — Episode 2 22:28

1M ago22:28

22:28

In this episode of IM: Unfiltered, Lindy Tentinger, President of VGM & Associates and Ike Isaacson, SVP of Government & Regulatory Relations with VGM Government dive into the incredible impact one person can make—yes, that one is YOU. Join us as we challenge you to turn intention into action and share the stories that move us all. Whether it's goin…

1
New Audit Traps Revealed in the 2026 Medicare Physician Fee Schedule 28:24

1M ago28:24

28:24

The Centers for Medicare & Medicaid Services (CMS) recently released the 2026 Medicare Physician Fee Schedule. And while that’s not breaking news, the important news is that you and your team could benefit by understanding its hidden traps – so you can protect your revenue. During the next live edition of Monitor Monday, senior healthcare analyst F…

1
The Nuts and Bolts of GA Therapy: Wrapping Up the Conversation 21:55

1M ago21:55

21:55

How do you decide when GA patients are ready for complement inhibition—and how do you keep them on therapy in the real world? In episode 3 of The Nuts and Bolts of GA Therapy, moderator Charles Wykoff, MD, PhD, speaks with Kenneth Fan, MD, MBA, and Sruthi Arepalli, MD, about early vs conservative initiation, nuanced counseling on expectations and s…

1
AAO '25: GLP-1s and AMD, and Parity in Retina Care 32:30

1M ago32:30

32:30

What do GLP-1 receptor agonists mean for the future of retinal disease? Aleksandra Rachitskaya, MD, joins us to review the ever-evolving data on the relationship between retinal disease and GLP-1 RA use. Could these drugs protect against the development of retinal disease? And Julia Haller, MD, explains her vision of what the future of retina looks…

1
New Sepsis Definition Could Help You Achieve Denial Avoidance 30:12

1M ago30:12

30:12

Recently, a new version of the Sequential Organ Failure Assessment (SOFA) score was introduced. Known as SOFA-2, this new definition aligns with organ dysfunction measurement in critically ill adults with current clinical practices, especially those diagnosed with sepsis. Published in the Journal of the American Medical Association (JAMA) on Oct. 2…

1
CGM Market Pulse: Innovations and Integrations in HME 25:11

2M ago25:11

25:11

In this episode, join Matt Edwards, CEO, GEMCO Medical and Heather Trumm, Partner Account Manager, VGM & Associates, as they explore the latest advancements in Continuous Glucose Monitoring (CGM) technology—from extended wear times to new pump integrations—making diabetes management easier and more effective for patients. We also unpack what these …

1
Late-Breaking Talks at AAO '25: Phase 3 for Uveitic Macular Edema and GATHER2 OLE 16:27

2M ago16:27

16:27

Could a biologic that addresses uveitic macular edema (UME) change the treatment landscape for uveitis patients? Rahul Khurana, MD, joins us to review data from the MEERKAT and SANDCAT trials assessing vamikibart (Genentech/Roche) for UME. And Arshad Khanani, MD, MA, joins us to review the open-label extension study of GATHER2. What effect does ava…

1
AAO '25: Dry AMD Pipeline and Oral Treatment for Stargardt Disease 27:20

2M ago27:20

27:20

The dry AMD pipeline is packed. Join New Retina Radio as we break it down with Peter Kaiser, MD, whose podium presentation at AAO 2025 offered a survey of developmental projects in dry AMD. What should we look forward to? And Michel Michaelides, MD, shares details from the DRAGON study, which examined the safety and efficacy of tinlarebant (Belite …

1
DME 08 - South Davis UT Family Hostage Rescue & HRT 15:28

2M ago15:28

15:28

DME 08By Jon Becker

1
Pursuit Leads to Unrelated Family Hostage Situation and HRT 51:15

2M ago51:15

51:15

In September of 2021 a suspect involved in a carjacking and attempted homicide led police in a vehicle pursuit that ended in a car crash in Farmington Utah. The suspect fled on foot across Interstate 15 into a residential neighborhood prompting patrol officers to establish a perimeter and begin a search with a K9 unit. During the search a single gu…

1
DME Supplier Pays $37 Million to Resolve FCA Allegations 30:12

2M ago30:12

30:12

Durable medical equipment (DME) supplier Semler Scientific Inc., along with a former distributor, Bard Peripheral Vascular Inc. and its related companies, have agreed to pay $37 million to resolve allegations that they violated the False Claims Act (FCA) by knowingly causing and conspiring to cause the submission of false claims to Medicare for pho…

1
The Nuts and Bolts of GA Therapy: The Discussions Continue 30:08

2M ago30:08

30:08

How do you create clear, durable treatment plans for real-world GA patients? In episode 2 of The Nuts and Bolts of GA Therapy, host Charles Wykoff, MD, PhD, joins Hasenin Al-khersan, MD, and Nakul Singh, MD, to dissect real-world cases and discuss choosing monthly or EOM week dosing regimens, engaging caregivers, and reconciling clinical trial data…

1
Late-Breaking Talks at AAO '25: Gene Therapy for RP and NPDR 25:54

2M ago25:54

25:54

Could optogenetics represent the innovative thinking needed to restore some function in retinitis pigmentosa (RP) patients? Allen Ho, MD, joins us to discuss the state of play in optogenetics, specifically regarding MCO-010 (Nanoscope Therapeutics). What have we seen in the several years since the first patients with RP were dosed with MCO-010 in t…

1
Arun J. Sanyal, MBBS, MD - Making Connections to Improve Patient Care in Obesity, Metabolism, and Liver Health 44:00

2M ago44:00

44:00

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups. For the full presentation, downloadable Practice Aids, slides, and complete CME information, and to apply for credit, please visit us at PeerView.com/GPQ865. CME credit will…

1
From Polypharmacy To Clarity: Building A Culture Of Ongoing Med Rec 27:34

2M ago27:34

27:34

A single, accurate medication list can prevent harm, yet it’s often the messiest part of home visits. We unpack how to turn a kitchen-table pile of bottles into a clear, living record that protects patients, reduces polypharmacy, and keeps agencies compliant. Drawing on decades at the bedside and in surveys, we walk through the moments where discre…

1
Alexis Ogdie, MD, MSCE, Robert H. Eckel, MD, FAHA, FACC - Tackling Obesity in Psoriatic Arthritis: Key to Better Outcomes and Overall Health 56:09

2M ago56:09

56:09

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups. For the full presentation, downloadable Practice Aids, slides, and complete CME/AAPA/IPCE information, and to apply for credit, please visit us at PeerView.com/CKQ865. CME/A…

1
A New Drug Crisis Soon Facing American Hospitals 31:09

2M ago31:09

31:09

America’s hospitals will soon face an unprecedented rebate-based prescription drug model, come Jan. 1 – that’s when there will be as many as 10 major drugs subject to Medicare price caps. This development is expected to create administrative and financial challenges for hospitals, which will have to pay the commercial price for such drugs while wai…

1
Home-Based Care on the Rise: Understanding Data Driven DME Strategies 21:51

2M ago21:51

21:51

This episode dives into the evolving landscape of the Durable Medical Equipment (DME) industry, where market growth is being driven by rising patient volumes and shifting care preferences. With demand projected to surge through 2033, the conversation explores how providers are adapting to meet the needs of a more dispersed and aging population. We …

1
Tactical Longevity – Dr. Jenny Prohaska 1:02:20

2M ago1:02:20

1:02:20

My guest today is Dr. Jenny Prohaska, a clinical psychologist who has spent her career on the front lines of trauma and high-stakes performance. Jenny trained in neuro -rehabilitation psychology at the University of Kansas Medical Center, working with patients and staff in trauma, ICU, and burn units, where she built her expertise in how the brain …

1
The Lowdown on the Shutdown 28:18

2M ago28:18

28:18

This marks the third week of the federal government shutdown: an epic failure of congressional leaders from both political parties who couldn’t agree on how fund the government for the fiscal year that began Oct. 1. And now many experts inside and outside of government believe this could be the longest shut down in history, surpassing the previous …

1
During Case Management Week: Unpacking Healthcare Cuts 59:14

2M ago59:14

59:14

You’re invited to go behind the scenes and listen as case managers tell their stories – of long hours, little sleep, and always being ambushed by a bell ringing for help. These unsung heroes of healthcare are receiving their moment in the sun during the next live edition of Monitor Mondays, with a special 60-minute broadcast. The first half of the …

1
New Retina Radio Journal Club w/ VBS: Time-Driven Cost Analysis of PRP: Dollars, Minutes, and Patient Care 19:50

3M ago19:50

19:50

How do costs and reimbursements shape practice patterns regarding panretinal photocoagulation (PRP)? Niki Kothari, MD, moderates a discussion with Jesse Sengillo, MD, and Nicholas Farber, MD, about a new time-driven activity-based costing study by Berkowitz et al. The panel explores how procedure time, margins, and CMS reimbursement affect the role…

1
The Nuts and Bolts of GA Therapy: The Opening Sessions 22:16

3M ago22:16

22:16

How do retina specialists first broach the topic of complement inhibition for GA therapy? In episode 1 of this miniseries, moderator Charles Wykoff, MD, PhD, speaks with Maryam Ghiassi, MD, MHS, and Matthew Cunningham, MD, about timing treatment conversations, managing patients with one good and one bad eye, and addressing whether patients can main…

1
DME 007 - Bakersfield PD Hostage Rescue 12:24

3M ago12:24

12:24

By Jon Becker

1
Hostage Rescue Under Explosive Threat - Bakersfield PD SWAT 1:25:04

3M ago1:25:04

1:25:04

On October 12th, 2020, Bakersfield police responded to a hospital on a domestic violence call to a female who had been hit in the head with a hammer by her ex-husband. When patrol officers arrived at the suspect's house, the male suspect exited the home, screaming at police and threw an improvised explosive device at officers. Negotiations with the…

1
Court Vacates RAVD 2023 Final Rule 29:41

3M ago29:41

29:41

By Frank Cohen, MPA | Adam Brenman | Knicole Emanuel, Esq. | David Glaser, Esq. | Ronald Hirsch FACP

1
Keeping Patients at the Center of GA Therapy: Preserving Vision vs Restoring Vision 15:37

3M ago15:37

15:37

How should retina specialists reframe their approach to GA therapy? In the final episode of this New Retina Radio miniseries, moderator John Kitchens, MD joins experts Margaret Chang, MD, MS; David Eichenbaum, MD; and Ferhina Ali, MD, MPH, to explore how to shift doctor mindsets from restoring vision to preserving it. The panel discusses challenges…

1
Keeping Patients at the Center of GA Therapy: Dosing Schedules, AREDS Vitamins, and Photobiomodulation 15:57

3M ago15:57

15:57

Should GA therapy start monthly—or is less-than-monthly treatment enough? In episode 3 of this New Retina Radio miniseries, moderator John Kitchens, MD joins David Eichenbaum, MD; Margaret Chang, MD, MS; and Ferhina Ali, MD, MPH, to share best practices in real-world GA care. The panel debates dosing strategy in light of long-term data, compares sa…